NCT00150787View on ClinicalTrials.gov

Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Epilepsy, Tonic-clonic
Interventions
DRUG

LEVETIRACETAM

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00150787 - Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy. | Biotech Hunter | Biotech Hunter